Federated Hermes’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $102K | Buy |
2,831
+553
| +24% | +$18.9K | ﹤0.01% | 1609 |
|
|
2026
Q1 | $75.3K | Sell |
2,278
-559
| -20% | -$23.7K | ﹤0.01% | 1628 |
|
|
2025
Q4 | $131K | Buy |
2,837
+1,965
| +225% | +$82.2K | ﹤0.01% | 1551 |
|
|
2025
Q3 | $30.5K | Buy |
872
+350
| +67% | +$12.2K | ﹤0.01% | 1752 |
|
|
2025
Q2 | $15.4K | Sell |
522
-79
| -13% | -$2.25K | ﹤0.01% | 1751 |
|
|
2025
Q1 | $17.9K | Sell |
601
-2,466
| -80% | -$75.4K | ﹤0.01% | 1743 |
|
|
2024
Q4 | $87.9K | Sell |
3,067
-327,426
| -99% | -$10.8M | ﹤0.01% | 1587 |
|
|
2024
Q3 | $12.8M | Buy |
330,493
+1,027
| +0.3% | +$36.6K | 0.03% | 520 |
|
|
2024
Q2 | $10.6M | Sell |
329,466
-65
| -0% | -$2.25K | 0.03% | 539 |
|
|
2024
Q1 | $12.8M | Buy |
329,531
+116,763
| +55% | +$4.09M | 0.03% | 520 |
|
|
2023
Q4 | $6.55M | Buy |
212,768
+91,911
| +76% | +$2.3M | 0.02% | 656 |
|
|
2023
Q3 | $2.7M | Buy |
120,857
+18,464
| +18% | +$421K | 0.01% | 843 |
|
|
2023
Q2 | $2.2M | Buy |
102,393
+29,223
| +40% | +$663K | 0.01% | 921 |
|
|
2023
Q1 | $1.76M | Buy |
+73,170
| New | +$1.94M | ﹤0.01% | 999 |
|
|
2022
Q3 | – | Sell |
-9
| Closed | -$1K | – | 2155 |
|
|
2022
Q2 | $1K | Sell |
9
-262,095
| -100% | -$4.41M | ﹤0.01% | 2032 |
|
|
2022
Q1 | $5.34M | Sell |
262,104
-232
| -0.1% | -$4.38K | 0.01% | 765 |
|
|
2021
Q4 | $4.9M | Buy |
262,336
+69,781
| +36% | +$1.36M | 0.01% | 815 |
|
|
2021
Q3 | $3.8M | Buy |
192,555
+20,951
| +12% | +$453K | 0.01% | 890 |
|
|
2021
Q2 | $4.06M | Buy |
171,604
+171,379
| +76,168% | +$3.96M | 0.01% | 891 |
|
|
2021
Q1 | $5K | Sell |
225
-3,826
| -94% | -$90.9K | ﹤0.01% | 2062 |
|
|
2020
Q4 | $81K | Sell |
4,051
-31,134
| -88% | -$608K | ﹤0.01% | 1765 |
|
|
2020
Q3 | $733K | Sell |
35,185
-93,017
| -73% | -$1.68M | ﹤0.01% | 1367 |
|
|
2020
Q2 | $2.24M | Sell |
128,202
-130,270
| -50% | -$2.55M | 0.01% | 957 |
|
|
2020
Q1 | $4.22M | Buy |
258,472
+95,210
| +58% | +$1.97M | 0.01% | 676 |
|
|
2019
Q4 | $3.36M | Buy |
163,262
+83,572
| +105% | +$1.39M | 0.01% | 887 |
|
|
2019
Q3 | $915K | Buy |
79,690
+66,315
| +496% | +$757K | ﹤0.01% | 1304 |
|
|
2019
Q2 | $176K | Buy |
+13,375
| New | +$179K | ﹤0.01% | 1557 |
|
|
2018
Q4 | – | Sell |
-190
| Closed | -$3K | – | 2210 |
|
|
2018
Q3 | $3K | Sell |
190
-30
| -14% | -$532 | ﹤0.01% | 2106 |
|
|
2018
Q2 | $5K | Sell |
220
-411
| -65% | -$10.1K | ﹤0.01% | 2011 |
|
|
2018
Q1 | $16K | Sell |
631
-128
| -17% | -$3.05K | ﹤0.01% | 1798 |
|
|
2017
Q4 | $14K | Buy |
+759
| New | +$10.9K | ﹤0.01% | 1823 |
|
|
2016
Q1 | – | Sell |
-192
| Closed | -$5K | – | 2112 |
|
|
2015
Q4 | $5K | Buy |
+192
| New | +$4.04K | ﹤0.01% | 1869 |
|
Other funds holding COLL
JT
EAM
Federated Hermes's COLL Position: Q2 2026 in Review
Federated Hermes increased its Collegium Pharmaceutical (COLL) stake by 24% in Q2 2026, buying an estimated $18.9K and bringing the position to 2,831 shares worth $102K. The position accounts for ﹤0.01% of the portfolio, ranked #1609.
Federated Hermes first reported a position in COLL in Q4 2015 and has held it in 32 quarters since. The position peaked at $12.8M in Q1 2024. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.
- Federated Hermes held 2,831 shares of Collegium Pharmaceutical worth $102K as of Q2 2026.
- Federated Hermes bought 553 Collegium Pharmaceutical shares in Q2 2026, an estimated $18.9K.
- Collegium Pharmaceutical made up ﹤0.01% of Federated Hermes's portfolio in Q2 2026, its #1609 holding.
- Federated Hermes first reported a position in Collegium Pharmaceutical in Q4 2015 and has held it in 32 quarters since.
- Federated Hermes's Collegium Pharmaceutical position peaked at $12.8M in Q1 2024.
- 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.
Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.